MedPath

Effect of Topical Lidocaine Spraying on the Vocal Cords Before Intubation During Robotic Surgery: a Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Lidocaine Spray
Intubation
Robotic Surgery
Interventions
Drug: Normal Saline (0.9% NaCl)
Drug: Lidocaine %2 ampoule
Registration Number
NCT07154628
Lead Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Brief Summary

Endotracheal intubation is a respiratory management technique used during general anesthesia. It is essential for certain surgical procedures as it ensures a secure airway for the patient.

However, during the placement of the endotracheal tube, the passage of the tube through the vocal cords can cause pain stimulation, leading to an increase in heart rate and blood pressure. Lidocaine reversibly blocks the conduction of nerve impulses along nerve fibers by preventing the movement of sodium ions across the nerve membrane. Topical application of lidocaine near the vocal cords before endotracheal tube placement may be a way to reduce the surgical pleth index and changes in vital signs (heart rate, blood pressure) caused by excessive endotracheal tube stimulation.

This study aims to investigate the benefit of topical spraying of lidocaine on the vocal cords before endotracheal tube placement during routine da Vinci surgery. The primary outcomes were the pharmacological effects of spraying either lidocaine or normal saline (control group) on the vocal cords. These included: post-intubation hypertension (defined as an increase in systolic blood pressure of more than 20% from baseline), changes in mean arterial pressure before and after intubation, and objective pain indices such as the Surgical Pleth Index. Secondary outcomes included post-intubation hypotension (defined as mean arterial pressure less than 70 mmHg), as well as postoperative complaints and severity of sore throat, pain on swallowing, and hoarseness.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • ASA classification I~III, age 18~69 y/o, BMI 18~35kg/m2, elective robotic surgery under general anesthesia
Exclusion Criteria
  • Allergy or contraindication to lidocaine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lidocaine groupNormal Saline (0.9% NaCl)The group of patient will receive lidocaine spraying on vocal cord before intubation
Control groupLidocaine %2 ampouleThe group of patient will receive normal saline spraying on vocal cord before intubation
Primary Outcome Measures
NameTimeMethod
post-intubation hypertensionFrom enrollment to the end of surgery

defined as an increase in systolic blood pressure of more than 20% from baseline

changes in mean arterial pressure before and after intubationFrom enrollment to the end of surgery
objective pain indices (Surgical Pleth Index)From enrollment to the end of surgery
Secondary Outcome Measures
NameTimeMethod
post-intubation hypotensionFrom enrollment to postoperative day 1

defined as mean arterial pressure less than 70 mmHg

pain on swallowingFrom enrollment to postoperative day 1

During patients' stay in post-anesthetic care unit and our postoperative follow-up visiting at postoperative day 1, we will check the patients if they have any complaint of pain on swallowing.

postoperative sore throatFrom enrollment to postoperative day 1

During patients' stay in post-anesthetic care unit and our postoperative follow-up visiting at postoperative day 1, we will check the patients if they have any complaint of postoperative sore throat.

hoarsenessFrom enrollment to postoperative day 1

During patients' stay in post-anesthetic care unit and our postoperative follow-up visiting at postoperative day 1, we will check the patients if they have any complaint of hoarseness.

Trial Locations

Locations (1)

Kaohsiung Medical University Chung-Ho Memorial Hospital

🇨🇳

Kaohsiung City, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital
🇨🇳Kaohsiung City, Taiwan
Kuang-I Cheng, PhD
Contact
886-7-3121101
kuaich@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.